Medicaid has not been a big topic on the campaign trail, though it provides insurance for 73 million people. Still, some ...
Centene shares jumped after the insurer said that the financial squeeze to its Medicaid business would soon ease as it ...
The biggest increase in 2-year survival associated with Medicaid expansion was among patients with stage III disease, with a ...
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
Like other payers, Centene flagged a mismatch between patient acuity and payment rates in Medicaid. But the insurer said a ...
Centene's Medicaid revenue fell slightly in the third quarter as costs outpaced the payment increases states implemented.
Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly ...
Centene reported a third quarter profit of $713 million as Obamacare enrollment and premium revenue helped overcome a big dip ...
The presidential election, loss of higher federal funding, inflationary pressures and other challenges are leaving state ...
While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...
New research published online-ahead-of-print in Journal of the National Comprehensive Cancer Network found that people with ...
The Centers for Medicare & Medicaid Services (CMS) announced the approval of Medicaid coverage for Traditional Healing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback